ClinVar Miner

Submissions for variant NM_003060.4(SLC22A5):c.391G>A (p.Glu131Lys)

gnomAD frequency: 0.00001  dbSNP: rs1321705165
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001938987 SCV002200628 uncertain significance Renal carnitine transport defect 2022-08-09 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 131 of the SLC22A5 protein (p.Glu131Lys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. ClinVar contains an entry for this variant (Variation ID: 1429538). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Giacomini Lab, University of California, San Francisco RCV001938987 SCV002576670 uncertain significance Renal carnitine transport defect 2022-10-03 criteria provided, single submitter research
Fulgent Genetics, Fulgent Genetics RCV001938987 SCV002816639 uncertain significance Renal carnitine transport defect 2021-11-13 criteria provided, single submitter clinical testing
GeneDx RCV003107900 SCV003761757 uncertain significance not provided 2023-01-25 criteria provided, single submitter clinical testing Described as a non deleterious variant, with functional studies of carnitine uptake by OCNT2 in transfected cells showing no significant difference compared to wildtype (Rodin M et al., 2020); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: Rdin2020[DegreeProject])
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre RCV001938987 SCV005016525 uncertain significance Renal carnitine transport defect 2024-03-14 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV003107900 SCV005075097 uncertain significance not provided 2024-06-01 criteria provided, single submitter clinical testing SLC22A5: PM2, PP3
Breakthrough Genomics, Breakthrough Genomics RCV003107900 SCV005188588 uncertain significance not provided criteria provided, single submitter not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.